Identification of Six N7-Methylguanosine-Related miRNA Signatures to Predict the Overall Survival and Immune Landscape of Triple-Negative Breast Cancer through In Silico Analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Six N7-Methylguanosine-Related miRNA Signatures to Predict the Overall Survival and Immune Landscape of Triple-Negative Breast Cancer through In Silico Analysis
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2022, Issue -, Pages 1-16
Publisher
Hindawi Limited
Online
2022-09-27
DOI
10.1155/2022/2735251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- WBSCR22 and TRMT112 synergistically suppress cell proliferation, invasion and tumorigenesis in pancreatic cancer via transcriptional regulation of ISG15
- (2022) Aamir Khan et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes
- (2022) Nikolaos Zacharakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression
- (2022) Jie Chen et al. Cancer Communications
- N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis
- (2022) Hui Han et al. Nature Communications
- CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
- (2021) Navid Sobhani et al. Cancers
- N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression
- (2021) Zihao Dai et al. MOLECULAR CELL
- METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation
- (2021) Esteban A. Orellana et al. MOLECULAR CELL
- Multi-omics integration of methyltransferase-like protein family reveals clinical outcomes and functional signatures in human cancer
- (2021) Ion John Campeanu et al. Scientific Reports
- The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition
- (2021) S. Loi et al. ANNALS OF ONCOLOGY
- WBSCR22 confers cell survival and predicts poor prognosis in glioma
- (2020) Yajie Chi et al. BRAIN RESEARCH BULLETIN
- No Evidence for N7-Methylation of Guanosine (m7G) in Human let-7e
- (2020) Jeppe Vinther MOLECULAR CELL
- Long non-coding RNA DLEUI promotes papillary thyroid carcinoma progression by sponging miR-421 and increasing ROCK1 expression
- (2020) Rui Li et al. Aging-US
- Triple negative breast cancer in the era of miRNA
- (2020) Hussein Sabit et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- miR-1915-3p inhibits Bcl-2 expression in the development of gastric cancer
- (2019) Hong-wei Cui et al. BIOSCIENCE REPORTS
- METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation
- (2019) Luca Pandolfini et al. MOLECULAR CELL
- Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing
- (2019) Christel Enroth et al. NUCLEIC ACIDS RESEARCH
- MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression
- (2019) Zhaozhou Ren et al. CANCER BIOLOGY & THERAPY
- Exploring specific prognostic biomarkers in triple-negative breast cancer
- (2019) Chang Bao et al. Cell Death & Disease
- CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
- (2019) Weikai Xiao et al. Aging-US
- The Biogenesis and Precise Control of RNA m6A Methylation
- (2019) Huilin Huang et al. TRENDS IN GENETICS
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
- (2018) Carsten Denkert et al. LANCET ONCOLOGY
- Genetic Markers in Triple-Negative Breast Cancer
- (2018) Zuzana Sporikova et al. Clinical Breast Cancer
- Triple-Negative Breast Cancer: Current State of the Art
- (2018) Francesca Rastelli et al. TUMORI
- 7-Methylguanosine Modifications in Transfer RNA (tRNA)
- (2018) Chie Tomikawa INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR-4326 promotes lung cancer cell proliferation through targeting tumor suppressor APC2
- (2017) Guopeng Xu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma
- (2017) Yong Wan et al. Oxidative Medicine and Cellular Longevity
- WBSCR22 confers oxaliplatin resistance in human colorectal cancer
- (2017) Dongmei Yan et al. Scientific Reports
- Expansion induced microRNA changes in bone marrow mesenchymal stromal cells reveals interplay between immune regulation and cell cycle
- (2016) Lotta Kilpinen et al. Aging-US
- miRNA expression profiling of ‘noninvasive follicular thyroid neoplasms with papillary-like nuclear features’ compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas
- (2016) Nicla Borrelli et al. MODERN PATHOLOGY
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma
- (2016) Shuguang Zhou et al. TUMOR BIOLOGY
- WBSCR22/Merm1 is required for late nuclear pre-ribosomal RNA processing and mediates N7-methylation of G1639 in human 18S rRNA
- (2014) Sara Haag et al. RNA
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- The widespread regulation of microRNA biogenesis, function and decay
- (2010) Jacek Krol et al. NATURE REVIEWS GENETICS
- MicroRNA: Mechanism of gene regulation and application to livestock1
- (2008) T. G. McDaneld JOURNAL OF ANIMAL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started